カテゴリー： Market Monitor Global, 世界, 医療/バイオ

PIG豚繁殖呼吸器症候群（PRRS）ワクチンの世界市場見通し2023年-2029年

◆英語タイトル：PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2503）◆商品コード：MMG23FB2503
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模と予測を収録しています。・世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「CH-1R株」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

PIG豚繁殖呼吸器症候群（PRRS）ワクチンのグローバル主要企業は、Merck、HIPRA、Sinopharm Animal Health Co., Ltd、Ceva Santé Animale、CAVAC、Bioveta、Jinyu Bio-Technology、Zoetis、Boehringer Ingelheim、Harbin Pharmaceutical Groupなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、PIG豚繁殖呼吸器症候群（PRRS）ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場：タイプ別市場シェア、2022年
・CH-1R株、PC株、その他

世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場：用途別市場シェア、2022年
・雌豚、雌豚

世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるPIG豚繁殖呼吸器症候群（PRRS）ワクチンのグローバル売上、2018年-2023年
・主要企業におけるPIG豚繁殖呼吸器症候群（PRRS）ワクチンのグローバル売上シェア、2022年
・主要企業におけるPIG豚繁殖呼吸器症候群（PRRS）ワクチンのグローバル販売量、2018年-2023年
・主要企業におけるPIG豚繁殖呼吸器症候群（PRRS）ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Merck、HIPRA、Sinopharm Animal Health Co., Ltd、Ceva Santé Animale、CAVAC、Bioveta、Jinyu Bio-Technology、Zoetis、Boehringer Ingelheim、Harbin Pharmaceutical Group

*************************************************************

・調査・分析レポートの概要
PIG豚繁殖呼吸器症候群（PRRS）ワクチン市場の定義
市場セグメント
世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模
世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模：2022年 VS 2029年
世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのPIG豚繁殖呼吸器症候群（PRRS）ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のPIG豚繁殖呼吸器症候群（PRRS）ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：CH-1R株、PC株、その他
PIG豚繁殖呼吸器症候群（PRRS）ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：雌豚、雌豚
PIG豚繁殖呼吸器症候群（PRRS）ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別PIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模 2022年と2029年
地域別PIG豚繁殖呼吸器症候群（PRRS）ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck、HIPRA、Sinopharm Animal Health Co., Ltd、Ceva Santé Animale、CAVAC、Bioveta、Jinyu Bio-Technology、Zoetis、Boehringer Ingelheim、Harbin Pharmaceutical Group
...

This report aims to provide a comprehensive presentation of the global market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine. This report contains market size and forecasts of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in global, including the following market information:
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine companies in 2022 (%)
The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
CH-1R Strain Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine include Merck, HIPRA, Sinopharm Animal Health Co., Ltd, Ceva Santé Animale, CAVAC, Bioveta, Jinyu Bio-Technology, Zoetis and Boehringer Ingelheim, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Segment Percentages, by Type, 2022 (%)
CH-1R Strain
PC Strain
Others
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Segment Percentages, by Application, 2022 (%)
Gilts
Sows
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine revenues share in global market, 2022 (%)
Key companies PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
HIPRA
Sinopharm Animal Health Co., Ltd
Ceva Santé Animale
CAVAC
Bioveta
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim
Harbin Pharmaceutical Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, market overview.
Chapter 2: Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Overall Market Size
2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size: 2022 VS 2029
2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players in Global Market
3.2 Top Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Companies Ranked by Revenue
3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Companies
3.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Companies
3.5 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players in Global Market
3.8.1 List of Global Tier 1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Markets, 2022 & 2029
4.1.2 CH-1R Strain
4.1.3 PC Strain
4.1.4 Others
4.2 By Type – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue & Forecasts
4.2.1 By Type – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, 2018-2023
4.2.2 By Type – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, 2024-2029
4.2.3 By Type – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales & Forecasts
4.3.1 By Type – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, 2018-2023
4.3.2 By Type – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, 2024-2029
4.3.3 By Type – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2022 & 2029
5.1.2 Gilts
5.1.3 Sows
5.2 By Application – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue & Forecasts
5.2.1 By Application – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, 2018-2023
5.2.2 By Application – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, 2024-2029
5.2.3 By Application – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales & Forecasts
5.3.1 By Application – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, 2018-2023
5.3.2 By Application – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, 2024-2029
5.3.3 By Application – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2022 & 2029
6.2 By Region – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue & Forecasts
6.2.1 By Region – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, 2018-2023
6.2.2 By Region – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, 2024-2029
6.2.3 By Region – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales & Forecasts
6.3.1 By Region – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, 2018-2023
6.3.2 By Region – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, 2024-2029
6.3.3 By Region – Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, 2018-2029
6.4.2 By Country – North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, 2018-2029
6.4.3 US PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.4.4 Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.4.5 Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, 2018-2029
6.5.3 Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.5.4 France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.5.5 U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.5.6 Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.5.7 Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.5.9 Benelux PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, 2018-2029
6.6.3 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.6.4 Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.6.5 South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.6.7 India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, 2018-2029
6.7.2 By Country – South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, 2018-2029
6.7.3 Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.7.4 Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, 2018-2029
6.8.3 Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.8.4 Israel PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
6.8.6 UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Product Offerings
7.1.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 HIPRA
7.2.1 HIPRA Company Summary
7.2.2 HIPRA Business Overview
7.2.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Product Offerings
7.2.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 HIPRA Key News & Latest Developments
7.3 Sinopharm Animal Health Co., Ltd
7.3.1 Sinopharm Animal Health Co., Ltd Company Summary
7.3.2 Sinopharm Animal Health Co., Ltd Business Overview
7.3.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Product Offerings
7.3.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Sinopharm Animal Health Co., Ltd Key News & Latest Developments
7.4 Ceva Santé Animale
7.4.1 Ceva Santé Animale Company Summary
7.4.2 Ceva Santé Animale Business Overview
7.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Product Offerings
7.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Ceva Santé Animale Key News & Latest Developments
7.5 CAVAC
7.5.1 CAVAC Company Summary
7.5.2 CAVAC Business Overview
7.5.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Product Offerings
7.5.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 CAVAC Key News & Latest Developments
7.6 Bioveta
7.6.1 Bioveta Company Summary
7.6.2 Bioveta Business Overview
7.6.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Product Offerings
7.6.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Bioveta Key News & Latest Developments
7.7 Jinyu Bio-Technology
7.7.1 Jinyu Bio-Technology Company Summary
7.7.2 Jinyu Bio-Technology Business Overview
7.7.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Product Offerings
7.7.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Jinyu Bio-Technology Key News & Latest Developments
7.8 Zoetis
7.8.1 Zoetis Company Summary
7.8.2 Zoetis Business Overview
7.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Product Offerings
7.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Zoetis Key News & Latest Developments
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Company Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Product Offerings
7.9.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Boehringer Ingelheim Key News & Latest Developments
7.10 Harbin Pharmaceutical Group
7.10.1 Harbin Pharmaceutical Group Company Summary
7.10.2 Harbin Pharmaceutical Group Business Overview
7.10.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Product Offerings
7.10.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Harbin Pharmaceutical Group Key News & Latest Developments
8 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Capacity, Analysis
8.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Capacity, 2018-2029
8.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Supply Chain Analysis
10.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Value Chain
10.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Upstream Market
10.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ PIG豚繁殖呼吸器症候群（PRRS）ワクチンの世界市場見通し2023年-2029年(PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 生殖遺伝医療機器のグローバル市場展望 2023年-2029年：試薬、医療機器、ソフトウェア
  • ブタサーコウイルス2型（PCV2）ワクチンのグローバル市場予測2023-2029
  • 豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンのグローバル市場予測2023-2029
  • 過敏性腸症候群治療薬の世界市場見通し2023年-2029年
  • コンパートメント症候群圧力モニタリングの世界市場見通し2023年-2029年